Metabolic Syndrome
Metabolic syndrome may play role in HFpEF risk
Lifestyle changes as important as medication to prevent, treat type 2 diabetes
Severe obesity increases likelihood of PCOS, metabolic syndrome
Approximately 1 in 4 Swedish women with severe obesity has polycystic ovary syndrome and more than 40% have metabolic syndrome, although women with and without PCOS had comparable body composition measurements and experienced similar weight loss during a dietary intervention, according to findings published in Clinical Endocrinology.
Metabolic syndrome does not hinder Ilumya efficacy in psoriasis
Q&A: This is an ‘exciting time’ for PBC treatment options
Primary biliary cholangitis is a chronic autoimmune disease that causes progressive destruction of the bile ducts. While the disease is considered rare with fewer than 200,000 cases in the U.S. per year, many physicians and patient advocacy groups have made strides toward increasing awareness about the disease, as early diagnosis and treatment can help to manage complications and prevent progression of inflammation and fibrosis.
Spotting NASH Starts With Simple Calculations
Approximately 30% of Americans have fatty liver, but only a small proportion have progressed to nonalcoholic steatohepatitis. One of the complications that we face in finding these patients is that our current treatment guidelines for nonalcoholic fatty liver disease do not recommend routine screening. Additionally, it is not feasible to send every patient with potential risk factors for an invasive procedure like liver biopsy. What we have at our disposal, however, are some very simple noninvasive biomarkers and tools to help stratify which patients should be followed for fatty liver and its progression.
Top stories in endocrinology: Healthy lifestyle can reduce diabetes risk by 75%; breastfeeding, sugar-sweetened beverages may influence childhood obesity risk
Among the top stories in endocrinology last week were findings that suggested adults who practiced a combination of healthy lifestyle factors more than halved their risk for developing type 2 diabetes and a study that determined children exposed to gestational diabetes in utero who were exclusively breastfed were less likely to develop obesity if intake of sugar-sweetened beverages was also low.
Fatty liver update: 6 reports on comorbidity risks
Approximately 30% of Americans have fatty liver disease often driven by obesity and alcohol use. Fatty liver disease leads to many other complications including fasting glucose impairment or diabetes, cardiovascular disease, certain cancers, and can exacerbate the effects of other liver diseases such as hepatitis C.
Fasting not required for metabolic syndrome assessment
NASH more likely, liver fibrosis less likely with increasing C-peptide levels in type 2 diabetes
Adults with type 2 diabetes and higher C-peptide levels are more likely to develop simple nonalcoholic fatty liver disease and nonalcoholic steatohepatitis compared with those with lower levels, according to findings published in DiabetesMetabolism Research and Reviews. In contrast, those with higher C-peptide levels are less likely to have advanced fibrosis.